Your browser doesn't support javascript.
loading
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.
Gato-Cañas, Maria; Zuazo, Miren; Arasanz, Hugo; Ibañez-Vea, Maria; Lorenzo, Laura; Fernandez-Hinojal, Gonzalo; Vera, Ruth; Smerdou, Cristian; Martisova, Eva; Arozarena, Imanol; Wellbrock, Claudia; Llopiz, Diana; Ruiz, Marta; Sarobe, Pablo; Breckpot, Karine; Kochan, Grazyna; Escors, David.
Affiliation
  • Gato-Cañas M; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Zuazo M; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Arasanz H; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain; Department of Oncology, Complejo Hospitalario de Navarra, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Ibañez-Vea M; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Lorenzo L; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Fernandez-Hinojal G; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain; Department of Oncology, Complejo Hospitalario de Navarra, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Vera R; Department of Oncology, Complejo Hospitalario de Navarra, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Smerdou C; Center for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Avenida Pio XII, 55, 31008 Pamplona, Spain.
  • Martisova E; Center for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Avenida Pio XII, 55, 31008 Pamplona, Spain.
  • Arozarena I; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain.
  • Wellbrock C; Division of Molecular and Clinical Cancer Sciences, The University of Manchester, Oxford Road, M13 9PL Manchester, UK.
  • Llopiz D; Center for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Avenida Pio XII, 55, 31008 Pamplona, Spain.
  • Ruiz M; Center for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Avenida Pio XII, 55, 31008 Pamplona, Spain.
  • Sarobe P; Center for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Avenida Pio XII, 55, 31008 Pamplona, Spain.
  • Breckpot K; Department of Biomedical Sciences, Vrije Universiteit Brusels, Laarbeeklaan 103/E, 1090 Jette, Brussels, Belgium.
  • Kochan G; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain. Electronic address: grazyna.kochan@navarra.es.
  • Escors D; Department of Oncology, Navarrabiomed-Biomedical Research Centre, IdiSNA, 31008 Pamplona, Navarra, Spain; Division of Infection and Immunity, Rayne Institute, University College London, WC1E 6JF London, UK. Electronic address: d.escors@ucl.ac.uk.
Cell Rep ; 20(8): 1818-1829, 2017 Aug 22.
Article in En | MEDLINE | ID: mdl-28834746
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferons / B7-H1 Antigen / Neoplasms Limits: Animals / Female / Humans Language: En Journal: Cell Rep Year: 2017 Document type: Article Affiliation country: España Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferons / B7-H1 Antigen / Neoplasms Limits: Animals / Female / Humans Language: En Journal: Cell Rep Year: 2017 Document type: Article Affiliation country: España Country of publication: Estados Unidos